Radiation and immunotherapy before surgery for head and neck cancer
Treatments studied
Part of Cancer, Ear, nose & throat clinical trials.
This study tests giving a short course of targeted radiation (SBRT) along with immunotherapy and a targeted drug before surgery for advanced head and neck cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of head and neck cancer (squamous cell carcinoma) that can be removed with surgery.
- Your doctor has tested your tumor for HPV (a virus) using a p16 test.
- You are between 18 and 70 years old.
- You do not have a serious autoimmune disease or take high doses of daily steroids (more than 20mg of prednisone).
- You are in reasonably good health (able to walk and care for yourself) and your organs work well enough to handle the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving an immunotherapy drug called sintilimab before and after surgery can help treat head and neck cancer. The drug aims to boost your immune system to fight the cancer, and the goal is to improve outcomes when combined with the standard surgical treatment.
This study tests a new treatment approach for head and neck cancer that can't be removed with surgery. You would get a combination of an immunotherapy drug (which helps your immune system fight cancer) and chemotherapy first, followed by the standard chemoradiation therapy.
This trial tests giving a combination of two drugs (an immunotherapy drug called a PD-1 inhibitor and a targeted therapy called cetuximab) before surgery to shrink head and neck cancers. The goal is to see if this approach lowers the chance of the cancer coming back after surgery.
This trial tests a combination of low-dose radiation and an immunotherapy drug (similar to Keytruda) given before surgery for advanced head and neck cancer. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests combining radiation therapy with immunotherapy and chemotherapy before surgery for advanced oral or throat cancer. The goal is to see if this approach can shrink the tumor and improve treatment outcomes.
This trial compares giving immunotherapy alone versus immunotherapy plus focused radiation before surgery for head and neck cancer. The goal is to see if adding radiation helps shrink the tumor and improve outcomes.
Hear when a new Head and Neck Squamous Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.